Explore 3 Stock Ideas & Industry Insights Download Free Report

Bioceres Crop Solutions Corp

Company price
0.2448 USD 0.01 ( 4.57%)
Last update at 2026-11-09T17:56:00Z
VOLUME
44054
Market Cap
38.55M

Momentum Score

…

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.21
Low
0.25
High
52 Week Price Range
0.35
Low
5.18
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Bioceres Crop Solutions Corp provides seeds, crop protection, biologicals and digital agriculture solutions to farmers, with a commercial focus in Latin America. Long-term growth may be supported by wider adoption of seed traits and biological inputs and by geographic expansion, which could diversify revenue and increase recurring sales.
Primary investment risks include regulatory and commercialization uncertainty for biotech traits, commodity and currency volatility in its markets, and execution and financing challenges during scaling.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.23
Dividend Yield
-
Revenue TTM
318.16M
Revenue Per Share
5.02
Gross Profit TTM
125.43M
Debt / Equity
1.05
ROE
-18.95%
Net Debt
243.91M
ROCE
-0.89%
Diluted EPS TTM
-1.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Income before tax -53.90M 10.04M 19.11M 14.06M 14.06M
Minority interest 3.43M -3.01M -1.39M -3.10M -3.10M
Net income -51.80M 3.24M 18.78M -3.91M -7.20M
Selling general administrative 72.47M 77.45M 70.23M 51.67M 42.99M
Selling and marketing expenses 15.88M 16.82M 16.71M 6.50M 16.03M
Gross profit 130.20M 181.59M 180.25M 126.44M 126.44M
Reconciled depreciation 22.18M 21.30M 19.39M 19.39M 19.39M
Ebit -3.80M 34.16M 41.70M 39.87M 30.85M
Ebitda 13.59M 55.46M 61.09M 49.33M 40.03M
Depreciation and amortization 17.39M 21.30M 19.39M 9.46M 9.19M
Operating income -3.70M 44.82M 54.18M 39.87M 39.87M
Other operating expenses 337.00M 420.01M 365.13M 287.29M 288.13M
Interest expense 50.10M 26.87M 21.23M 14.95M 14.95M
Tax provision 1.27M 3.78M -1.07M -1.00M -1.00M
Net interest income -33.71M -26.87M -23.79M -35.30M -35.30M
Income tax expense 1.30M 3.78M -1.07M 17.97M 17.97M
Total revenue 333.30M 464.83M 419.45M 328.46M 328.46M
Total operating expenses 133.90M 136.77M 125.94M 85.27M 86.11M
Cost of revenue 203.10M 283.24M 239.20M 202.02M 202.02M
Total other income expense net -50.20M -34.79M -35.08M -25.81M -25.81M
Net income from continuing ops -58.85M 6.26M 20.17M 19.80M 19.80M
Net income applicable to common shares - - - 18.78M 18.78M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Total assets 763.65M 850.63M 818.06M 518.22M 518.22M
Intangible assets 181.17M 174.80M 173.78M 76.70M 76.70M
Other current assets 5.83M 10.24M 11.17M 4.91M 4.91M
Total liab 468.43M 501.06M 487.56M 359.92M 359.92M
Total stockholder equity 262.81M 314.01M 298.85M 127.36M 127.61M
Other current liab 9.51M 13.28M 11.98M 19.65M 10.80M
Common stock 0.01M 0.01M 0.01M 0.00M 0.00M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -65.04M -10.66M -13.90M -32.68M -32.68M
Other liab - - - 42.94M 42.94M
Good will 112.16M 112.34M 112.16M 36.07M 36.07M
Other assets - - - 13.47M 13.47M
Cash 32.70M 44.47M 48.13M 33.48M 33.48M
Total current liabilities 337.99M 329.51M 298.71M 222.67M 222.67M
Current deferred revenue 4.28M 3.92M 24.88M 5.90M 5.90M
Net debt 243.91M 226.47M 209.28M 136.31M 136.31M
Short term debt 228.88M 139.87M 111.50M 72.71M 72.71M
Short long term debt 222.00M 136.75M 107.64M 108.90M 108.90M
Short long term debt total 276.61M 270.95M 257.41M 169.79M 169.79M
Other stockholder equity 327.75M 294.01M 311.37M 158.06M 158.06M
Property plant equipment - - - 81.79M 81.79M
Total current assets 308.31M 408.67M 397.11M 297.71M 297.71M
Long term investments 39.37M 40.42M 39.74M 40.30M 40.30M
Net tangible assets - - - 12.65M 12.65M
Short term investments 2.04M 11.70M 11.92M 5.14M 5.14M
Net receivables 177.75M 216.03M 185.32M 128.08M 128.08M
Long term debt 38.20M 122.91M 135.88M 135.90M 135.90M
Inventory 89.99M 126.22M 140.57M 126.10M 126.10M
Accounts payable 91.58M 161.96M 146.29M 124.41M 124.45M
Accumulated other comprehensive income 0.09M 29.09M 1.12M 1.98M 1.98M
Non currrent assets other 26.76M 18.53M 6.15M 2.50M 2.50M
Non current assets total 455.33M 441.96M 420.94M 220.52M 220.52M
Capital lease obligations 16.41M 11.28M 13.89M 13.90M 13.90M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-12-31 2022-06-30
Investments -6.13M -28.73M -25.73M -25.73M -25.73M
Change to liabilities - - - 8.82M 8.82M
Total cashflows from investing activities -6.13M - - -25.73M -25.73M
Net borrowings -27.57M - - 59.22M 59.22M
Total cash from financing activities -50.71M -10.06M 32.95M 14.82M 14.82M
Change to operating activities - - - -4.46M -4.46M
Net income -58.85M 6.26M 20.17M -3.91M -3.91M
Change in cash -11.78M -3.66M 14.65M -2.57M -2.57M
Begin period cash flow 44.47M 48.13M 33.48M 36.05M 36.05M
End period cash flow 32.70M 44.47M 48.13M 33.48M 33.48M
Total cash from operating activities 49.91M 41.72M 2.59M -17.52M -17.52M
Depreciation 22.18M 21.30M 19.39M 9.19M 9.19M
Other cashflows from investing activities -8.97M - - - -
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory 34.91M 14.18M -11.07M -55.31M -55.31M
Change to account receivables 24.58M -51.65M -56.87M -24.97M -24.97M
Sale purchase of stock -0.93M -0.73M -3.00M -3.00M -3.00M
Other cashflows from financing activities -22.21M -27.65M -23.27M 139.49M -13.91M
Change to netincome - - - 48.22M 48.22M
Capital expenditures 14.61M 22.78M 22.56M 9.00M 9.00M
Change in working capital 19.30M -41.51M -85.11M -60.85M -60.85M
Stock based compensation 4.39M 14.13M 3.42M 1.43M 1.43M
Other non cash items 61.61M 37.76M 45.78M 18.65M 18.65M
Free cash flow 35.30M 18.93M -19.97M -26.51M -26.51M

Peer Comparison*

Sector: Basic Materials Industry: Agricultural Inputs

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIOX
Bioceres Crop Solutions Corp
0.01
4.57%
0.24 - 14.99 0.12 0.57 0.92 17.98
CTA-PB
E. I. du Pont de Nemours and Company
-0.10
0.18%
56.40 - - 3.43 - - -
CTVA
Corteva Inc
0.27
2.23%
12.16 49.93 19.65 3.12 2.19 3.23 19.19
CTA-PA
E. I. du Pont de Nemours and Company
-0.48
1.04%
45.52 - - 2.71 - - -
NTR
Nutrien Ltd
1.25
1.74%
72.72 15.94 14.90 1.38 1.42 1.72 7.72

Profile*

Bioceres Crop Solutions Corp

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Ocampo 210 bis, Rosario, Argentina, 2000

54 91 1347 24616

751

Name Title Year Born
Jose A. Roque Gen. Counsel NA
Dr. Federico Trucco Ph.D. Chairman & CEO 1977
Mr. Enrique López Lecube CFO & Exec. Director 1982
Mr. Jorge Wagner Chief Operating Officer 1969
Rodrigo Krause Head of Investor Relations NA
Mr. Ricardo Luis Yapur Managing Director of Latam Unit & Chief Commercial Officer 1958
Mr. Matti Tiainen Managing Director of North America & Europe 1989
Jose A. Roque General Counsel NA
Alex Garcia Managing Director of Seeds NA
Dr. Federico Trucco Ph.D. Executive Chairman & CEO 1977

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…